surpass cvot tirzepatide Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial SURPASS CVOT

The same platforms are also the birthplace of a number of beauty challenges that have gained traction over the years where mostly young females display their thinness

Patients should maintain adequate hydration and seek prompt medical advice if persistent vomiting, diarrhoea, or signs of dehydration occur

More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to westernised diets and more sedentary lifestyles

This is an important point for readers because people often assume that if a medicine is talked about in the news, it must now be easy to get from a GP

As a dual GIP/GLP-1 receptor agonist, tirzepatide works through two pathways rather than one, which clinical trials have shown produces greater average weight loss compared to semaglutide alone